Rituximab: A New Therapeutic Monoclonal Antibody for Non-Hodgkin's Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rituximab: A New Therapeutic Monoclonal Antibody for Non-Hodgkin's Lymphoma

Published:1998-05 Issue:3 Volume:6 Page:195-197
ISSN:1065-4704
Container-title:Cancer Practice
language:en
Short-container-title:Cancer Pract

Author:

Scott Shane D.

Publisher

Wiley

Subject

Oncology,General Nursing

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1523-5394.1998.006003195.x/fullpdf

Reference14 articles.

1. Classification and clinical course of low-grade non-Hodgkin's lymphomas with overview of therapy

2. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20

3. Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic Drugs

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The advancements and prospective developments in anti-tumor targeted therapy;Neoplasia;2024-10

2. Chemical Production of Cytotoxic Bispecific Antibodies Using the Ugi Multicomponent Reaction;ChemBioChem;2024-06-26

3. “ThermoTRP” Channel Expression in Cancers: Implications for Diagnosis and Prognosis (Practical Approach by a Pathologist);International Journal of Molecular Sciences;2023-05-22

4. Successful AAV8 readministration: Suppression of capsid‐specific neutralizing antibodies by a combination treatment of bortezomib and CD20 mAb in a mouse model of Pompe disease;The Journal of Gene Medicine;2023-05-02

5. Evolving therapeutic proteins to precisely kill cancer cells;Journal of Controlled Release;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3